Stockreport

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance Canada]

Roivant Sciences Ltd.  (ROIV) 
PDF Analysts noted the settlement, which involves paying up to $2.25 billion ?to a Roivant Sciences' Genevant subsidiary, and Arbutus Biopharma, would shift investor focus [Read more]